Reaction
Immunotoxicity reporting signals
As of the last recalculation, Immunotoxicity appears in 111 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is DURVALUMAB (PRR 252.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Durvalumab | 22 | 252.7 | 252.9 |
| Fosaprepitant Dimeglumine | 7 | 101.8 | 101.9 |
| Pembrolizumab | 37 | 98.4 | 98.5 |